📰 Fay Probert News
Fay Probert News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Fay Probert. Real-time updates on events, politics, business and more.
January 26, 2022
Dr. James Larkin discusses the benefits of biofluid metabolomics and how an NMR-based approach could help to improve the way that cancer is detected and monitored in patients with nonspecific symptoms.
January 18, 2022
A new type of blood test that has been at the centre of studies carried out by researchers at the University of Oxford, can be used to detect a range of cancers and whether these cancers have spread (metastasised) in the body. Click to read more...
January 13, 2022
A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms.
January 10, 2022
A University of Oxford study published in Clinical Cancer Research, a journal of the American Association for Cancer Research, outlines a new type of blood test that can be used to detect a range of cancers and whether these cancers have spread (meta
January 6, 2022
A NEW blood-based test is the first ever to simultaneously identify if a patient has cancer and if it has spread.
January 6, 2022
The test is a technological first in determining the metastatic status of a cancer without using prior insight of the primary cancer presented. - News - PharmaTimes
January 6, 2022
Study finds that a new diagnostic test using NMR metabolomics is able to detect cancer and identify metastatic disease in patients with concerning but non-specific symptoms.
January 6, 2022
A NEW blood-based test is the first ever to simultaneously identify if a patient has cancer and if it has spread.
January 5, 2022
The new test uses magnetic fields and radio waves to measure the different so-called metabolites in patients blood, the University of Oxford-led researchers explained.
January 5, 2022
A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients